Patrick M McCarthy (Patrick McCarthy)

Years Active: 2020-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Elizabeth Lee Carpenter, Spencer G Van Decar, Alexandra M Adams, Anne E O'Shea, Patrick M McCarthy, Robert Connor Chick, Guy Travis Clifton, Timothy J Vreeland, Franklin A Valdera, Ankur Tiwari, Diane Hale, Phillip Kemp Bohan, Annelies Hickerson, Todd Smolinsky, Katryna Thomas, Jessica Cindass, John Hyngstrom, Adam C Berger, James Jakub, Jeffrey J Sussman, Montaser F Shaheen, Xianzhong Yu, Thomas E Wagner, Mark Faries, George E Peoples
Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis. Journal for immunotherapy of cancer 11 (8) (2023)
Patrick M McCarthy, Matthew J Rendo, Matthew D Uy, Alexandra M Adams, Anne E O'Shea, Daniel William Nelson, Joshua L Fenderson, Katherine M Cebe, Robert W Krell, Guy T Clifton, George E Peoples, Timothy J Vreeland
Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Ductal Adenocarcinoma. OncoTargets and therapy 14 (2021)
Patrick M McCarthy, G Travis Clifton, Timothy J Vreeland, Alexandra M Adams, Anne E O'Shea, George E Peoples
AE37: a HER2-targeted vaccine for the prevention of breast cancer recurrence. Expert opinion on investigational drugs 30 (1) (2020)

Patrick M McCarthy.css-eqlu8i{font-size:small;padding-left:4px;} (Patrick McCarthy)